Ribonucleotide reductase and thymidine phosphorylation: Two potential targets of azodicarbonamide

Biochemical Pharmacology

Volumn 64, Issue 3, 2002, Pages 451-456

  Fagny, Christine ^a   Vandevelde, Michel ^b   Svoboda, Michal ^a   Robberecht, Patrick ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Hubriphar SA   (Belgium)

Author keywords

Azodicarbonamide; Ribonucleotide reductase; Thymidine phosphorylation

Indexed keywords

AZOFORMAMIDE; DEOXYCYTIDINE TRIPHOSPHATE; DEOXYRIBONUCLEOTIDE; HYDROXYUREA; METHOTREXATE; RIBONUCLEOTIDE REDUCTASE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; NUCLEOTIDE METABOLISM; PHOSPHORYLATION; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; AZO COMPOUNDS; DEOXYCYTOSINE NUCLEOTIDES; DEOXYGUANINE NUCLEOTIDES; DRUG INTERACTIONS; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PHOSPHORYLATION; RIBONUCLEOTIDE REDUCTASES; THYMIDINE; THYMINE NUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0036684563     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01185-1     Document Type: Article

References (21)

1. Azodicarbonamide, a potential anti-HIV drug
2. Azodicarbonamide inhibits T-cell responses in vitro and in vivo
3. Azodicarbonamide as a new T cell immunosuppressant: Synergy with cyclosporin A
4. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein
5. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins
6. Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy
7. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis
8. Enzymatic assay for quantification of deoxynucleoside triphosphates in human cells exposed to antiretroviral 2′,3′-dideoxynucleosides
9. T-lymphocytes from AIDS patients are unable to synthesize ribonucleotides de novo in response to mitogenic stimulation. Impaired pyrimidine responses are already evident at early stages of HIV-1 infection
10. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors
11. Regulation of human thymidine kinase during cell cycle
12. Hydroxyurea and HIV: 5 years later from antiviral to immune-modulating effects
13. Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudine
14. Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: A partial solution to Africa's HIV/AIDS problem?
15. Effect of methotrexate on deoxyribonucleotide pools and DNA synthesis in human lymphocytic cells
16. Vaccinia virus induces ribonucleotide reductase in primate cells
17. A model for the role of multiple cysteine residues involved in ribonucleotide reduction: Amazing and still confusing
18. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells
19. Properties of mitochondrial thymidine kinases of parental and enzyme-deficient HeLa cells
20. 2′-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase
21. Hydroxyurea inhibits thymidine kinase activity in regenerating rat liver